Selling Your Med Spa: What PE Buyers Are Actually Paying
Private equity is actively acquiring med spas and weight loss clinics. We have seen valuations around $2,500 per patient under the doctor\'s care. Here is what you need to know to sell for top dollar.
Selling Your Med Spa: What PE Buyers Are Actually Paying
Private equity has been aggressively acquiring medical spas, weight loss clinics, and aesthetic medicine practices for several years. If you own a med spa and have not thought seriously about your exit options, you may be leaving significant money on the table.
Our team has MBA and JD credentials, has operated the practices you run, and has direct relationships with the PE groups actively acquiring in this space. Here is what we know about what they are paying — and how to position your practice to command the highest multiple.
The PE Acquisition Wave in Medical Aesthetics
Private equity's interest in medical aesthetics is not a passing trend. It is driven by structural factors that are not going away:
Fragmented market — The medical spa and aesthetic medicine market is highly fragmented. PE firms see consolidation opportunity — buying multiple practices, standardizing operations, and creating regional or national platforms.
Recurring revenue — GLP-1 weight management programs, in particular, generate recurring monthly revenue from patients on ongoing protocols. PE buyers love recurring revenue.
Demographic tailwinds — Demand for aesthetic and wellness services continues to grow as the population ages and disposable income increases.
Telehealth scalability — Practices with telehealth components can scale patient volume without proportional increases in physical infrastructure.
What PE Buyers Are Actually Paying
Valuations in this space vary significantly based on practice characteristics, but here is what we have seen:
Per-patient valuations: We have seen PE groups paying approximately $2,500 per patient under the doctor's care for well-run practices with strong patient retention metrics.
EBITDA multiples: Practices with strong EBITDA are typically valued at 4–8x EBITDA, with higher multiples for practices with:
- Strong recurring revenue (GLP-1 programs, membership models)
- Multiple locations
- Telehealth capability
- Clean compliance records
- Strong medical director relationships
Revenue multiples: For practices with strong revenue but lower margins, buyers may use revenue multiples — typically 1–3x annual revenue depending on growth trajectory and margin profile.
What PE Buyers Look For
Understanding what PE buyers prioritize helps you position your practice for maximum value:
Clean Compliance Record
PE buyers conduct thorough due diligence. Any history of regulatory issues, board complaints, or litigation will either kill the deal or significantly reduce the price. A clean compliance record is table stakes.
Documented Patient Base
The $2,500/patient valuation assumes documented, active patients with established relationships. Practices with robust patient records, documented visit histories, and strong retention metrics command higher valuations.
Recurring Revenue
Practices with membership programs, subscription-based GLP-1 protocols, or other recurring revenue streams are significantly more attractive to PE buyers than practices with purely transactional revenue.
Scalable Operations
PE buyers are looking for practices they can replicate. Documented protocols, trained staff, and systems that do not depend entirely on the founder's personal relationships are highly valued.
Strong Medical Director Structure
A properly structured medical director relationship that will survive the transition is important. PE buyers are wary of practices where the medical director is the owner and will be leaving at close.
Clean Financials
Three years of clean, audited or reviewed financial statements are the minimum. PE buyers will scrutinize your financials closely. Practices with clean books sell faster and at better prices.
The Process: From Decision to Close
Here is how a typical med spa acquisition process works:
1. Confidential Valuation Before going to market, get a realistic valuation. This involves analyzing your patient base, revenue, EBITDA, and comparable transactions. We provide confidential valuations for practices considering a sale.
2. Positioning How you present your practice matters enormously. We help you build the narrative that maximizes your valuation — highlighting the metrics PE buyers care about and addressing potential concerns proactively.
3. Buyer Introductions We have direct relationships with the PE groups actively acquiring in this space. We make warm introductions to qualified buyers — not cold outreach to a list.
4. LOI and Due Diligence Once a buyer is interested, they will issue a Letter of Intent (LOI) outlining the proposed terms. Due diligence follows — typically 60–90 days of financial, legal, and operational review.
5. Close With proper preparation, the close process is manageable. Our JD credentials mean we can support the legal review process and help you understand what you are signing.
Buy-Side Advisory: We Work Both Sides
We are not just sell-side advisors. We also work with buyers — PE groups, strategic acquirers, and individual operators looking to acquire practices.
If you are looking to acquire a med spa or weight loss clinic, we can source off-market deals through our operator network, run due diligence, and structure transactions that protect your interests.
This Service Is Independent of Supply
Our M&A advisory services are available to any licensed medical practice — whether or not you use our compounding supply portal. If you are interested in exploring a sale or acquisition, reach out directly.
This content is for informational purposes only and does not constitute legal or financial advice. Consult with qualified legal and financial advisors regarding your specific situation.
Explore Topics
Written by
MedClinic Partners Editorial Team
B2B Medical Supply & Compounding Experts
The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.
